Recruitment now open for bone bruising trial
23 February, 2016Paradigm Biopharmaceuticals seeks to investigate if the drug ZILOSUL can resolve bone bruising arising from sporting or accidental injuries to the knee such as a ruptured anterior cruciate ligament (ACL).
Nerve stimulation studies for migraine sufferers
22 February, 2016electroCore is running two new trials of its gammaCore non-invasive vagus nerve stimulation (nVNS) therapy in episodic migraine.
Avita appoints new distributor, sells respiratory business
17 February, 2016Regenerative medicine company Avita Medical has appointed MSM Medical as its newest European distributor and sold its respiratory business to Medical Developments International.
Spinifex condoms — thinner than a human hair
12 February, 2016 by Adam FloranceThe secret to the world's thinnest, strongest latex condoms and surgical gloves may lie in the resin from spinifex grass.
Progress towards an all-in-one disease monitoring device
10 February, 2016Australian and British scientists are collaborating on the creation of a single miniature biodegradable device that can not only track a disease, but can also treat it.
Portable splint to be launched this year
09 February, 2016With the support of the Medical Device Partnering Program, Fluoro Medical will this year launch a foldable splint that can fit into a first aid kit.
Australian cancer drug licensed for $730m
01 February, 2016A promising new cancer drug, developed by the Cancer Therapeutics CRC (CTx), has been licensed to pharmaceutical company MSD for $730 million.
Proposed stem cell trial on track for approval
29 January, 2016Cynata Therapeutics has received favourable advice from the UK Medicines and Healthcare products Regulatory Agency, causing shares in the regenerative medicine company to jump by over 20%.
The eyes have it — bionically
28 January, 2016 by Adam FloranceUNSW engineers have developed a bionic eye with the potential to aid the blind in the same way that the cochlear implant has aided the deaf.
Zoetis to evaluate anti-infective product for animals
18 January, 2016Zoetis will evaluate the potential applications of Detach — a non-antibiotic, anti-infective product — for veterinary use in food production animals. Detach is a plant-based product that will help address concerns around the overuse of antibiotics in production animals.
New rabbit virus could be released this year
13 January, 2016The National Biosecurity Committee has agreed that the national release of Rabbit Haemorrhagic Disease Virus (RHDV1) K5 is now likely to take place in Spring 2016 or Autumn 2017.
Plant enzyme to make better medicines
22 December, 2015Researchers have identified and produced a key enzyme, found an in African plant, which can transform linear peptides into robust, chemically stable circular ones for use in pharmaceutical drug design.
Cynata signs LOIs regarding MSCs
21 December, 2015It's been a busy month for Cynata Therapeutics, with the company signing two letters of intent regarding the licensing and development of its proprietary MSC technology, Cymerus.
Paediatric CF trial reports positive results
17 December, 2015Pharmaxis has announced positive results for its recently completed Phase II trial of Bronchitol, a precision spray-dried form of mannitol, in children and adolescents with cystic fibrosis (CF).
Pharma R&D returns continue to decline
17 December, 2015The projected rate of return on pharmaceutical R&D has more than halved since 2010, from 10.1% to 4.2%, according to an annual study by the Deloitte Centre for Health Solutions.
